UHSF News

The company’s platform enables researchers to visualise and analyse protein structures at high resolution, reducing the time and cost of molecular imaging. Dutch biotech CryoCloud has secured a €2M Seed funding round to expand its cryo-electron microscopy SaaS platform, which aims to streamline drug development by automating complex structural biology workflows. The...

 Phlox Therapeutics raises 1.9M funding to develop RNA therapies for genetic laminopathies  The investor syndicate includes ROM Utrecht Region, FIRST Fund, Amsterdam-UMC Ventures and UHSF Funds support preclinical development of Phox’s lead program   Naarden, The Netherlands, 6 November 2024 – Phlox Therapeutics, a private biotechnology company focused on developing...

Utrecht Holdings (Knowledge Transfer Office of the UU and the UMCU) introduces a new, 7,5-million-euro seed fund to invest in science-based startups, Utrecht Holdings Seed Fund.

Cordys Analytics is proud to announce that it has been awarded a prestigious Eurostars grant.

We are happy to welcome our new portfolio company Cryocloud! Together with Nina Capital and ROM Utrecht Region we have invested € 500K to help the company in their mission to accelerate protein structure determination.

Ascenscia is an emerging tech startup in laboratory automation. Their product comprises a highly specialized voice assistant for scientific laboratories. It understands scientific terminologies and workflows efficiently and enables scientists to communicate with other lab systems by voice.

Synerkine Pharma, a Dutch biopharmaceutical company creating innovative pain solutions, today announced an extension of its Series A financing led by Flerie with support from new investors, InnovationQuarter Capital and Utrecht Health Seed Fund, and existing investor Thuja Capital.

The Academic Startup Competition (ASC) is a joint initiative of Techleap, UNL, NFU, NAE, UTwente, VU and EZK. The competition offers a curated batch of 20 selected academic startups the chance to showcase themselves to an audience of (international) investors and businesses.